202 related articles for article (PubMed ID: 24577133)
1. Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.
Berghoff AS; Ilhan-Mutlu A; Wöhrer A; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Melchardt T; Dome B; Heinzl H; Birner P; Preusser M
Strahlenther Onkol; 2014 Jul; 190(7):676-85. PubMed ID: 24577133
[TBL] [Abstract][Full Text] [Related]
2. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
Berghoff AS; Ilhan-Mutlu A; Dinhof C; Magerle M; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Pichler J; Hutterer M; Melchardt T; Bartsch R; Zielinski CC; Birner P; Preusser M
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e41-55. PubMed ID: 25256708
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
5. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
8. Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.
Spanberger T; Berghoff AS; Dinhof C; Ilhan-Mutlu A; Magerle M; Hutterer M; Pichler J; Wöhrer A; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Marosi C; Birner P; Prayer D; Preusser M
Clin Exp Metastasis; 2013 Apr; 30(4):357-68. PubMed ID: 23076770
[TBL] [Abstract][Full Text] [Related]
9. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
[TBL] [Abstract][Full Text] [Related]
10. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
11. Brain metastases of non-small cell lung cancer: prognostic factors and management.
Bacha S; Cherif H; Rabaa D; Habibech S; Cheikhrouhou S; Racil H; Chaouch N; Megdiche ML; Chabbou A
Tunis Med; 2018 Mar; 96(3):165-171. PubMed ID: 30325482
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
13. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
14. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.
Hung JJ; Yang MH; Hsu HS; Hsu WH; Liu JS; Wu KJ
Thorax; 2009 Dec; 64(12):1082-9. PubMed ID: 19778933
[TBL] [Abstract][Full Text] [Related]
17. Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases.
Chen K; Yu X; Zhang F; Xu Y; Zhang P; Huang Z; Fan Y
Lung Cancer; 2018 Nov; 125():8-13. PubMed ID: 30429042
[TBL] [Abstract][Full Text] [Related]
18. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
19. Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.
Laurinavicius A; Green AR; Laurinaviciene A; Smailyte G; Ostapenko V; Meskauskas R; Ellis IO
Oncotarget; 2015 Dec; 6(38):41134-45. PubMed ID: 26512778
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
